SLC17A9 and type 2 diabetes mellitus: Interestingly, glutamine, the transport substrate of VNUT (SLC17A9), plays a regulatory role in insulin secretion, and therefore, clodronate has been demonstrated to have therapeutic effects on T2D and NASH in mice models (Hasuzawa et al., 2021).